Reliq Health Techniques (RHT.V) Buy, Sell or…

Reliq Health Techniques (RHT.V)

0.22

+0.01 (2.38%)

as of Jan 16, 2024, 8:59:56 pm Market Open.

52 watching

DON'T BUY

Healthcare tech company.
Have recently been short the stock in the past.
Not sure how financials are going to improve.
Poor management of company.
Not a good long term holding.

COMMENT

Underlying business has been operating fantastically. Comes down to size and market cap. Still ramping up.

TOP PICK

It provides software for hardware for patients in their homes. Has 8 1/2 million in revenue up from 1 1/2 million the year before. It expects to have 100 000 patients at $50 per month per patient with maybe a 50% margin by the end of this year. It had a couple of false starts and is now at an inflection point. It was a top pick in the past and he has just bought back in. The company may do a buy back and is a possible takeover target.

PAST TOP PICK

(A Top Pick Oct 15/21, Down 54%) Their software connects to hardware so that people can monitored health ailments at home. FHT has been adding patient groups. The business offers recurring revenues whereby they're paid each month in US dollars. They project they will be EBITDA-positive this year. He got stopped-out of this, but wants to get back in. He sees potential. The CEO owns a lot of shares.

PAST TOP PICK

(A Top Pick Sep 02/21, Down 56%) More electronic home care will eventually bring down health care costs. It is signing more doctors' groups, etc. but still needs time to get patients hooked up. It should have 200 000 patients in the system next year with each one paying $40 U.S. per month. A high margin business. Looking for it to deliver

COMMENT

He shorted it because of poor valuation. You should read the short report that came out a couple of months ago.

PAST TOP PICK

(A Top Pick Sep 02/21, Down 61%) It is in the home monitoring business which could be huge one day. The business is operating well and signing up more patients. It receives around $50.00 per patient per month. It is a good time to buy now. A small cap.

BUY

Real-time, remote medical reporting from patient to care providers. Fits and starts over the years. Should be rolling up to cashflow positive. Nice runway with great growth rate. Adding new partners. Monthly subscription. Could have a bright future in next couple of years.

TOP PICK

Remote monitoring business. When people leave the hospital, they have the technology to help monitor them. Gives the ability to track and keep healthcare costs down. Continues to add more doctor groups and healthcare regions that are recurring revenue streams. $24M run rate for this year. Margin is 45%. Valuation is attractive.

TOP PICK

Remote monitoring of chronic disease. Real-time reporting to doctors. Slowed by Covid. Cashflow positive this quarter. Subscription model. Solid growth trajectory. CEO has a lot of skin in the game. No dividend.

BUY

It has a great product and is coming back after stubbing its toe three years ago. The market now likes it. Good opportunity for the company going forward, because telemedicine is in vogue and the US government will pay for results-based compensation.

WATCH

They said they will be cash flow positive moving into 2020. If they have the growth rate they are projecting, then you will see the stock start to move again. Right now it is in the penalty box.

DON'T BUY

It hasn't done well due to accounting issues. He recommnded it before, but hasn't gone back to this. Too many compliance issues here. He's heard that revenues and contracts look positive. No, he's been burned and avoids this.

DON'T BUY

A former top pick. They have long-term potential, but need to show they can add clients and be cash-flow positive. The stock is starting to recover.

DON'T BUY

He exited this story and is not going back to it because of structural problems. But it has gone up since then.

Showing 1 to 15 of 37 entries

Reliq Health Techniques (RHT.V) Frequently Asked Questions

What is Reliq Health Techniques stock symbol?

Reliq Health Techniques is a Canadian stock, trading under the symbol RHT.V (previously RHT-X on Stockchase) on the TSX Venture Exchange (RHT-CV). It is usually referred to as TSXV:RHT or RHT.V

Is Reliq Health Techniques a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on RHT.V (previously RHT-X on Stockchase) on Stockchase. Read the latest expert commentary for Reliq Health Techniques.

Is Reliq Health Techniques a good investment or a top pick?

Reliq Health Techniques was recommended as a Top Pick by Peter Imhof on 2019-06-13. Read the latest stock experts ratings for Reliq Health Techniques.

Why is Reliq Health Techniques stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Reliq Health Techniques.

Is Reliq Health Techniques worth watching?

Reliq Health Techniques is followed by 52 investors on Stockchase and is a trending stock that is worth watching.

What is Reliq Health Techniques stock price?

On 2024-01-16, Reliq Health Techniques (RHT.V) stock closed at a price of $0.22.

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Reliq Health Techniques (RHT.V)